The struggle against infections of cardiac implantable electrical devices: the burden of costs requires new personalized solutions-Reference-Cited by-同舟云学术

The struggle against infections of cardiac implantable electrical devices: the burden of costs requires new personalized solutions

Published:2018-04-17 Issue:12 Volume:20 Page:1877-1879
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Boriani Giuseppe¹,Elsner Christian²,Diemberger Igor³

Affiliation:

1. Cardiology Division, Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo, 71, Modena, Italy

2. Managing Direction Department, University Hospital Schleswig-Holstein, Lübeck, Germany

3. Department of Experimental, Diagnostic and Specialty Medicine, Institute of Cardiology, University of Bologna, Policlinico S.Orsola-Malpighi, Bologna, Italy

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/20/12/1877/26926845/euy049.pdf

Reference11 articles.

1. From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems;Diemberger;Expert Rev Med Devices,2011

2. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study;Clémenty;Europace,2018

3. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction;Diemberger;Expert Rev Med Devices,2013

4. Mortality and cost associated with cardiovascular implantable electronic device infections;Sohail;Arch Intern Med,2011

5. Predictors of long-term survival free from relapses after extraction of infected CIED;Diemberger;Europace,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator;Journal of Cardiovascular Electrophysiology;2023-12-04

2. Special Issue: “Biophysics, Arrhythmias and Pacing”;Biology;2023-04-08

3. Transvenous Lead Extraction in Patients with Cardiac Implantable Device: The Impact of Systemic and Local Infection on Clinical Outcomes—An ESC-EHRA ELECTRa (European Lead Extraction Controlled) Registry Substudy;Biology;2022-04-18

4. A Historical Perspective of Cardiac Implantable Electronic Device Infection: How a Menace Can Drive Technological and Clinical Improvement;Hearts;2021-03-30

5. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2020-02-26